Top Tech Companies in NYC, NY (10,000+)

Strong Revenue Growth: Revenue expanded at a faster year-over-year pace in the latest quarter, with multi-year increases continuing from prior fiscal years and momentum building into fiscal 2027. Recent disclosures indicate broad-based gains across subscriptions and both cloud and self-managed offerings.

Healthy Cash Flow: Operating cash flow rose sharply year over year, and free cash flow expanded alongside improving operating margins. There is also a shift to GAAP profitability, signaling stronger operating leverage.

Customer Loyalty & Retention: A high net ARR expansion rate indicates existing customers are spending more over time, complementing steady additions to the total customer base. Atlas-related consumption from larger existing accounts is cited as a key driver of subscription growth.

Strong Revenue Growth: Recent results show Peacock revenue up 54% year over year to $1.90 billion, Studios up 25% to about $3 billion, and NBCUniversal media and theme-park revenue up 23% to $10.7 billion in Q2 2026. Earlier in 2026, the parks business also rose 24% on the launch of Epic Universe.

Profitability: Peacock reached a key inflection with its first quarterly pre-tax profit of $189 million alongside paid subscribers rising to 48 million in Q2 2026. This points to improving streaming economics within the portfolio.

Future-Ready Strategy: Management is reshaping the portfolio by planning to spin off NBCUniversal and Sky into a standalone public company positioned to pursue growth across parks, film/TV, streaming, sports and news. The 2025 shareholder letter also highlights studios, streaming and parks as principal growth drivers representing a large share of Comcast’s revenue.

Strong Revenue Growth: Reported roughly 70% year-over-year revenue growth in 2024 alongside expectations of 10M+ room nights points to strong top-line momentum. Independent press coverage corroborated these figures during the 2024 financing round.

Profitability: The company was described as profitable at scale around its 2024 funding milestone, indicating growth accompanied by operational discipline. Continued expansion into 2025–2026 has been paired with statements of cash-flow positivity.

Investor Backing & Capital Strength: A $140M Series C at a $2.1B valuation and a funding history totaling over $200M signal strong access to capital and investor confidence. The rising valuation from 2021 to 2024 underscores sustained financial backing.

Strong Revenue Growth: Revenue has increased for multiple consecutive years, surpassing $3.0B in 2025 with continued growth into early 2026, including positive organic gains across all major segments. Filings indicate the trajectory is broad-based rather than acquisition-driven.

Profitability: Profitability is expanding faster than sales, with strong adjusted EBITDA growth and notable margin improvement in 2025. Subsequent quarterly updates show further gains, reinforcing operating leverage.

Healthy Cash Flow: Operating cash flow increased to roughly $600M in 2025, with stronger free cash flow supporting continued investment in labs and capacity expansion. This cash generation underpins ongoing growth initiatives.

Market Expansion: New enterprise wins and the move to serve firms from solo practices to large national enterprises point to a broadened addressable market. A New York City technology and sales hub and additional broker-dealer adoptions reinforce an expanding commercial footprint.

Product Line Growth: The acquisition of Parrot AI and its launch as a standalone advisor product, alongside offerings like a CRM+ for independent RIAs, indicate active portfolio expansion. Continued AI-native feature releases suggest investment in broader, deeper capabilities.

Future-Ready Strategy: Positioning as an AI-native wealth operating system and appointing a new CEO and CRO for the next phase of growth signal preparation for evolving market demands. Company statements about continued growth and organizational investment support a forward-looking posture.

Strong Revenue Growth: Company statements describe being on track for higher net revenue, and earlier filings documented substantial year-over-year expansion. Additional references point to rising contribution metrics over recent years.

Customer Loyalty & Retention: Company updates highlight record-high satisfaction and retention alongside a recent step-up in new-customer signups. These signals point to a stable, expanding customer base.

Product Line Growth: The business continues broadening its offering beyond core PEO into payroll, benefits, HR tools, and international employment, described under a “One Justworks” strategy. New capabilities and partnerships indicate ongoing investment in breadth.

Strong Revenue Growth: Reported results show consistent top-line increases through 2025 and into 2026, including a sharp acceleration in Q2 2026. Guidance was raised above $1B for 2026, underscoring momentum.

Strategic Partnerships: Long-term, often exclusive relationships with tier‑one rights holders such as the NFL (through 2029), Football DataCo/Premier League (through 2029) and the NCAA (through 2032) reinforce commercial visibility. These agreements expand distribution and underpin growth across betting and media.

Innovation-Driven Growth: Product advances like GeniusIQ, BetVision, and Second Spectrum tracking are cited as drivers of expanding media and betting solutions. This innovation push aligns with rapid Media segment growth and broader market expansion.

Strong Revenue Growth: Disclosures indicate revenue grew 137% in 2024 and 160% in the first nine months of 2025, reaching $783.7M for that period. Gains in average daily client balances and trading volume further underscore broad-based top-line acceleration.

Profitability: Net income turned meaningfully positive, with $89.1M in 2024 and $157.2M in the first nine months of 2025. This profitability alongside rapid scaling supports financial stability.

Market Expansion: The company expanded beyond U.S. prime brokerage into UK and European equities (e.g., LSE clearing membership) and pursued APAC access via regulatory approvals and acquisitions. It also broadened offerings across futures, fixed income, options, digital assets, and investment banking.

Investor Backing & Capital Strength: Funding is described as including a $30M Series B led by Andreessen Horowitz, bringing total backing to about $50M, signaling strong capital support for scaling. Investor commentary highlights conviction in Camber’s execution and claims-data advantage.

Market Expansion: Operations are reported to have broadened from an initial behavioral-health focus into additional care verticals and across all 50 states, alongside rising claims volume and provider reach. Company materials cite millions of claims processed and coverage of large billable amounts.

Strong Hiring & Retention: Hiring activity is ongoing, with the company described in the 51–200 employee range and noting its biggest hiring quarter in 2025. Open roles and expansion of enterprise go-to-market roles indicate continued team scaling.

Market Expansion: Public materials indicate expansion from serving 100+ organizations in 2022 to 400+ institutions by 2025, including moves into telecom and government with FedRAMP Ready status enabling federal opportunities. Evidence also points to deeper enterprise reach, including 11 of the 15 largest U.S. banks and 6 of the top 10 credit unions.

Product Line Growth: The offering has broadened from synthetic identity fraud into identity theft, first‑party fraud, and a CIP/KYC suite (e.g., CIP Match & Watchlists), later adding analyst tooling like Intercept. These additions expand addressable use cases across financial services and adjacent verticals.

Strategic Partnerships: Ecosystem ties include a FICO Industry Vanguard Decision Award with direct integration of SentiLink’s Identity Theft Score into the FICO Marketplace, alongside collaborations such as Yardi, Taktile, and a state‑level selection by Florida’s AHCA. These channels and validations open distribution and reinforce product relevance with large enterprises.

Investor Backing & Capital Strength: Funding announcements describe a $27M Series A led by Emergence with participation from Lux and Susa, signaling resources to scale product and team. Additional references point to continued expansion activity, including new client migrations and an expanding footprint.

Innovation-Driven Growth: Materials consistently portray an AI-native fund administration platform built around a proprietary general ledger, automation, and integrated portfolio/LP features. Case studies and descriptions highlight rapid migrations and faster closes (e.g., Day‑0 financials), indicating product-led momentum.

Strong Hiring & Retention: Hiring pages list multiple open roles across engineering, product, go‑to‑market, fund accounting, and operations, suggesting active headcount growth. Third‑party listings also show a growing team band alongside ongoing recruitment.

Profitability: Profitability is depicted as strong, with non-GAAP operating margins near 40% and improved GAAP net income. Feedback suggests this strength persists even amid slow top-line growth.

Healthy Cash Flow: Cash generation is highlighted as substantial, including FY2025 free cash flow above $1B and significant unlevered free cash flow in Q2 2026. Feedback suggests robust cash flow supports buybacks and financial flexibility.

Resilient & Sustainable Growth: Core operations are portrayed as stabilizing in 2026 with low single-digit revenue and ARR growth excluding FormSwift. Feedback suggests paying users have resumed modest sequential increases, indicating resilience.

Strong Revenue Growth: ARR is reported to have exceeded $600M by late 2025 and continued upward into 2026, indicating substantial monetization progress. Directionally rising figures from 2020–2026 support a clear upward trajectory despite private-company reporting limits.

Market Expansion: User scale reportedly surpassed 100M by 2024 with more than half of the Fortune 500 using the product and a large international user mix, pointing to expanding geographic and enterprise reach. An increasing share of paying customers and deeper enterprise penetration reinforce breadth beyond individual users.

Innovation-Driven Growth: AI capabilities—ranging from Notion AI to autonomous agents—are described as major growth levers, with over half of ARR linked to AI-enabled customers. Product additions like agents and calendar broaden the suite and appear to lift adoption and ARPU.

Strong Revenue Growth: Revenue is rising at double-digit rates across recent periods, and management has increased full-year guidance, underscoring continued momentum. Growth is visible in both recent quarters and the prior year, indicating sustained top-line expansion.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with data-licensing/Insights activity increasing alongside clinical testing volumes. This mix reduces reliance on a single line of business and supports multiple growth vectors.

Strategic Partnerships: Collaborations with major biopharmaceutical companies and broader rollouts of platforms such as Next signal expanding commercial reach. Announced initiatives like a large whole‑genome dataset and work with firms including Merck reinforce external demand for the platform.

Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.

Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.

Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.

Market Expansion: The platform’s footprint expanded from 400 participating sites in 2022 to 6,000+ sites by 2026, with presence across 50+ countries and 25+ sponsors. Evidence indicates marketplace adoption more than doubled in 2023 and activity surpassed 100 trials by 2024.

Product Line Growth: The offering broadened from a marketplace into AI-powered patient pre-screening and integrated workflows, with reported operational time savings and enrollment improvements in case studies. Subsequent integrations with CRIO, RealTime eClinical, and eClinPro signal continued platform expansion.

Strategic Partnerships: Relationships include major pharmaceutical organizations (e.g., 16 of the top 30 in 2024 and now 25+ sponsors) and ecosystem deals such as RealTime eClinical (50+ networks representing 2,000+ sites) plus CRIO/eClinPro integrations. These ties appear to extend distribution and enrich data used for site selection and enrollment.

Strong Revenue Growth: Revenue has risen strongly across 2025–2026, with the latest quarter marking the company’s 11th consecutive period of top-line expansion. Momentum is driven by continued gains in its Core Advertising business.

Profitability: Adjusted EBITDA expanded materially, with margins improving alongside scale, indicating solid operating leverage. Recent quarters show profitability strengthening even as the business invests for growth.

Healthy Cash Flow: Operating and free cash flow increased sharply on a trailing twelve‑month basis. Cash generation supports reinvestment and a stronger balance sheet following debt reduction.

Strong Revenue Growth: Top-line revenue is reported to have grown strongly on a multi-year basis through 2023, with additional indications of continued increases into 2025–2026. This provides the clearest quantitative signal of momentum for a private company with limited disclosures.

Market Expansion: The provider network and product footprint have broadened, including new launches such as programmatic access and a consumer health media offering alongside partnerships that extend reach. These moves show growth beyond core point-of-care screens into adjacent adtech and consumer channels.

Investor Backing & Capital Strength: Advent International’s 2025 agreement to acquire the company and continued investment signal substantial sponsor support for scaling. Such backing typically underwrites further network growth and product innovation.

Strong Revenue Growth: Revenue is described as rising at a very strong pace for multiple consecutive years, including a major surge in 2024. This sustained momentum indicates meaningful top-line expansion while advancing toward profitability.

Investor Backing & Capital Strength: Financing activity includes a late-stage equity round and substantial cumulative funding alongside expanded facilities. These signals point to continued access to capital that supports scaling credit and liquidity products.

Product Line Growth: Offerings have broadened beyond core banking into paycheck advances, fee-free overdraft, credit building, savings, teen accounts, and crypto. This expansion suggests more monetization paths and deeper engagement per customer.

Market Expansion: Operations span numerous U.S. cities and key European hubs, and examples such as multi-location laptop programs and a CETF-supported initiative point to activity at broader geographic scale.

Product Line Growth: The offering has evolved into a software-enabled hardware-lifecycle platform with asset tracking, reporting, and APIs, alongside expanded device retrievals covering laptops, phones, tablets, and monitors. This broadening increases addressable use cases.

Strategic Partnerships: Documented collaborations include a CETF–Revivn program cited by the California Public Utilities Commission and large-scale work with Block to repurpose thousands of laptops across global sites. These relationships extend reach and validate operational scale.